Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity
Author:
Affiliation:
1. Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Centre of Serbia, Dr. Subotica 13, 11000 Belgrade, Serbia
2. Faculty of Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia
Abstract
Funder
Ministry of Science, Serbia
Publisher
Hindawi Limited
Subject
Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://downloads.hindawi.com/journals/ije/2015/390185.pdf
Reference45 articles.
1. Plasminogen activator inhibitors
2. PAI-1 and Diabetes: A Journey From the Bench to the Bedside
3. Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina
4. In young post-myocardial infarction male patients elevated plasminogen activator inhibitor-1 correlates with insulin resistance and endothelial dysfunction
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1);Seminars in Thrombosis and Hemostasis;2022-12-15
2. A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease;Frontiers in Cardiovascular Medicine;2021-04-16
3. Serum protein signature of coronary artery disease in type 2 diabetes mellitus;Journal of Translational Medicine;2019-01-24
4. Influence of skeletal muscle mass and fat mass on the metabolic and inflammatory profile in sarcopenic and non-sarcopenic overfat elderly;Aging Clinical and Experimental Research;2018-09-03
5. mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?;Oxidative Medicine and Cellular Longevity;2018-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3